Post Profile






Viral particles support prophylactic vaccination against breast cancer

Artificial structures of tumor antigens, so-called mimotopes, applied in vaccinations of cancer patients can trigger a long-term immune response. For the vaccine, however, a carrier is required that triggers an immune response itself. A team of researchers showed in laboratory tests that virus-like particles of harmless adeno-associated viruses (AAV) are particularly suitable as carriers.
read more

share

Related Posts


Anti-Melanoma Vaccine Tested For Anti-Cancer Immune Response

Health : Medical News Today

Cancer vaccines prime the immune system to attack cancer cells, decreasing tumor progression. IL-12p70, a molecule produced by certain types of immune cells, has been shown to reduce tumor progression, but delivering it as part of a...

New Analysis of Old HIV Vaccines Finds Potentially Protective Immune Response

Health : Newswise Medical News

Applying the benefit of hindsight, researchers at Duke Medicine have reanalyzed the findings of two historic pediatric HIV vaccine trials with encouraging results. The vaccines had in fact triggered an antibody response -- now known...

Vaccine Stirs Immune Activity Against Advanced, Hard-to-Treat Leukemia

Health : Newswise Medical News

Dana-Farber scientists report in the Journal of Clinical Investigation they have developed a tumor vaccine based on the patient's tumor to create a strong and selective immune response in some chronic lymphocytic leukemia patients.

Vaccine 'Reprograms' Pancreatic Cancers to Respond to Immunotherapy

Health : Newswise Medical News

Researchers at the Johns Hopkins Kimmel Cancer Center have developed and tested a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, essentially reprogramming these intractable cancers and potentially...

Four-Week Vaccination Regimen Knocks Out Early Breast Cancer Tumors

Health : Newswise Medical News

Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete tumor e...

Comments


Copyright © 2016 Regator, LLC